206 related articles for article (PubMed ID: 31594997)
1. Modulation of PTH1R signaling by an ECD binding antibody results in inhibition of β-arrestin 2 coupling.
Sarkar K; Joedicke L; Westwood M; Burnley R; Wright M; McMillan D; Byrne B
Sci Rep; 2019 Oct; 9(1):14432. PubMed ID: 31594997
[TBL] [Abstract][Full Text] [Related]
2. Modulation of PTH1R signaling by an extracellular binding antibody.
Sarkar K; Joedicke L; Westwood M; Burnley R; Wright M; McMillan D; Byrne B
Vitam Horm; 2022; 120():109-132. PubMed ID: 35953107
[TBL] [Abstract][Full Text] [Related]
3. Analysis of parathyroid hormone (PTH)/secretin receptor chimeras differentiates the role of functional domains in the pth/ pth-related peptide (PTHrP) receptor on hormone binding and receptor activation.
Vilardaga JP; Lin I; Nissenson RA
Mol Endocrinol; 2001 Jul; 15(7):1186-99. PubMed ID: 11435617
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for parathyroid hormone-related protein binding to the parathyroid hormone receptor and design of conformation-selective peptides.
Pioszak AA; Parker NR; Gardella TJ; Xu HE
J Biol Chem; 2009 Oct; 284(41):28382-28391. PubMed ID: 19674967
[TBL] [Abstract][Full Text] [Related]
5. Disruption of β-catenin binding to parathyroid hormone (PTH) receptor inhibits PTH-stimulated ERK1/2 activation.
Yang Y; Wang B
Biochem Biophys Res Commun; 2015 Aug; 464(1):27-32. PubMed ID: 26047699
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone (PTH) and PTH-related peptide domains contributing to activation of different PTH receptor-mediated signaling pathways.
Cupp ME; Nayak SK; Adem AS; Thomsen WJ
J Pharmacol Exp Ther; 2013 Jun; 345(3):404-18. PubMed ID: 23516330
[TBL] [Abstract][Full Text] [Related]
7. Dimeric arrangement of the parathyroid hormone receptor and a structural mechanism for ligand-induced dissociation.
Pioszak AA; Harikumar KG; Parker NR; Miller LJ; Xu HE
J Biol Chem; 2010 Apr; 285(16):12435-44. PubMed ID: 20172855
[TBL] [Abstract][Full Text] [Related]
8. Functional modulation of PTH1R activation and signaling by RAMP2.
Nemec K; Schihada H; Kleinau G; Zabel U; Grushevskyi EO; Scheerer P; Lohse MJ; Maiellaro I
Proc Natl Acad Sci U S A; 2022 Aug; 119(32):e2122037119. PubMed ID: 35914163
[TBL] [Abstract][Full Text] [Related]
9. Identification of key phosphorylation sites in PTH1R that determine arrestin3 binding and fine-tune receptor signaling.
Zindel D; Engel S; Bottrill AR; Pin JP; Prézeau L; Tobin AB; Bünemann M; Krasel C; Butcher AJ
Biochem J; 2016 Nov; 473(22):4173-4192. PubMed ID: 27623777
[TBL] [Abstract][Full Text] [Related]
10. Molecular insights into peptide agonist engagement with the PTH receptor.
Cary BP; Gerrard EJ; Belousoff MJ; Fletcher MM; Jiang Y; Russell IC; Piper SJ; Wootten D; Sexton PM
Structure; 2023 Jun; 31(6):668-676.e5. PubMed ID: 37148874
[TBL] [Abstract][Full Text] [Related]
11. Unraveling the Interplay of Extracellular Domain Conformational Changes and Parathyroid Hormone Type 1 Receptor Activation in Class B1 G Protein-Coupled Receptors: Integrating Enhanced Sampling Molecular Dynamics Simulations and Markov State Models.
Li M; Zhang X; Li S; Guo J
ACS Chem Neurosci; 2024 Feb; 15(4):844-853. PubMed ID: 38314550
[TBL] [Abstract][Full Text] [Related]
12. Proline-rich motifs in the parathyroid hormone (PTH)/PTH-related protein receptor C terminus mediate scaffolding of c-Src with beta-arrestin2 for ERK1/2 activation.
Rey A; Manen D; Rizzoli R; Caverzasio J; Ferrari SL
J Biol Chem; 2006 Dec; 281(50):38181-8. PubMed ID: 17038311
[TBL] [Abstract][Full Text] [Related]
13. β-arrestin-biased agonism at the parathyroid hormone receptor uncouples bone formation from bone resorption.
Bohinc BN; Gesty-Palmer D
Endocr Metab Immune Disord Drug Targets; 2011 Jun; 11(2):112-9. PubMed ID: 21476967
[TBL] [Abstract][Full Text] [Related]
14. Translating in vitro ligand bias into in vivo efficacy.
Luttrell LM; Maudsley S; Gesty-Palmer D
Cell Signal; 2018 Jan; 41():46-55. PubMed ID: 28495495
[TBL] [Abstract][Full Text] [Related]
15. The parathyroid hormone receptorsome and the potential for therapeutic intervention.
Mahon MJ
Curr Drug Targets; 2012 Jan; 13(1):116-28. PubMed ID: 21777186
[TBL] [Abstract][Full Text] [Related]
16. Critical Extracellular Ca
Li M; Bao Y; Xu R; La H; Guo J
ACS Chem Neurosci; 2022 Jun; 13(11):1666-1674. PubMed ID: 35543321
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid Hormone Senses Extracellular Calcium To Modulate Endocrine Signaling upon Binding to the Family B GPCR Parathyroid Hormone 1 Receptor.
Culhane KJ; Belina ME; Sims JN; Cai Y; Liu Y; Wang PSP; Yan ECY
ACS Chem Biol; 2018 Aug; 13(8):2347-2358. PubMed ID: 29952553
[TBL] [Abstract][Full Text] [Related]
18. High-resolution crystal structure of parathyroid hormone 1 receptor in complex with a peptide agonist.
Ehrenmann J; Schöppe J; Klenk C; Rappas M; Kummer L; Doré AS; Plückthun A
Nat Struct Mol Biol; 2018 Dec; 25(12):1086-1092. PubMed ID: 30455434
[TBL] [Abstract][Full Text] [Related]
19. Arrestins in bone.
Bohinc BN; Gesty-Palmer D
Prog Mol Biol Transl Sci; 2013; 118():335-58. PubMed ID: 23764060
[TBL] [Abstract][Full Text] [Related]
20. β-Arrestin-biased signaling of PTH analogs of the type 1 parathyroid hormone receptor.
van der Lee MM; Verkaar F; Wat JW; van Offenbeek J; Timmerman M; Voorneveld L; van Lith LH; Zaman GJ
Cell Signal; 2013 Feb; 25(2):527-38. PubMed ID: 23159578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
